Interview with the ceo of agios. The stock got more than 6 today. Well find out why. And pay attention. Can you name todays mystery chart, the stock dropping at 1. 15 , bounced back a bit, had a bitter cold Holiday Season any ideas . Interesting that means something you probably do its a retailer. Well give you the name coming up but we begin with news on trade. The United States officially dropping the currency manipulator designation for china. Aman jabbers in washington with the developing story. Thats right, the treasury making it official at this hour, they are dropping the currency manipulator designation that they slapped on the chinese last year theyre removing it today. The Treasury Department saying in a statement thats for two reasons. One is the appreciation of the currency thats happened since last fall and the second one is agreements that theyve made inside the socalled phase one trade deal theyre saying in the agreement china has made enforceable commitments to refrain
Shazam is this an Artificial Intelligence play . Were going to look. Whats to buy ahead of tax reform debate on whether Airline Stocks could be the big beneficiaries of any tax bill. But we do start with the story thats taken wall street, main street, any street, frankly, by storm, and that is bitcoin. Bitcoin futures popping in their first full day of trading on the cboe Cnbcs Bob Pisani joining us with that story. Bob, everybody is talking about it. It is and its finally happened the good thing is at least trading has happened and relatively orderly we passed 18,000, folks. Bitcoin futures opened 6 00 last night eastern time, 15,000, moved up very, very quickly. Here you see its over 18,000. So its been small, 3,600 contracts, figure the math here. 17,000 p 17,000, 18,000 about 60 million. Thats not a lot but its a start at least heres whats important. Lets go over what exactly a futures contract is, why this is so important first of all, its just agreement to buy or sell a commodity
Mexicos first lady under fire for taking houses from companies doing direct business with her husband, the president of mexico. Now, for the first time she is speaking and Michelle Carusocabrera will tell us what she says. First to sue at the nasdaq where she will talk to the ceo of a company that just went public. Thats a great story and we will get to it in just a bit. We begin with mounting fears about the safety of cars on american roads. Regulators calling for a National Recall of millions of cars with air bags made by japanese auto parts supplier takata. Phil lebeau joins us live from the l. A. Auto show where air bags are stealing the show at this point. Phil to you. Reporter a lot of attention regarding the takata air bag recalls. A lot of people saying im not sure what is going on. Last night the National Safety Highway Administration held a Conference Call saying there should be a nationwide recall of millions of takata air bags. Prior to this it was regional recalls. They ar
Gained. 75 and the nasdaq also climbed. 75 . House of pleasure. What must happen now . What we have to ask, can keep this momentum going . What are the series of events that must unfold . How can the stock market continue to fly higher in the wake of its recent breather that ended today. Lets talk about what drove it down. The recent selling about the high Growth Stocks to take down as much of this redhot deal alibaba as possible, taking down being a technical term to get the red hot deal from a broker. As soon as the deals closed, as soon as the ipo Syndicate Managers let big funds know what they expect to get, did you notice the selling died down . The big funds know what to expect and they raised the cash they need so the alibabarelated selling seems to be at an end. Given that its been my principal worry for weeks now, im glad were past the point where alibaba and cue selling can hurt us. Now that the s p has built up over the next few week, what needs to any right to get us beyond
StockNews.com upgraded shares of Agios Pharmaceuticals (NASDAQ:AGIO – Free Report) from a sell rating to a hold rating in a research note issued to investors on Wednesday. Several other analysts also recently weighed in on AGIO. Royal Bank of Canada reduced their target price on Agios Pharmaceuticals from $43.00 to $42.00 and set an outperform […]